M
Mark E. Cooper
Researcher at University of Queensland
Publications - 1514
Citations - 141899
Mark E. Cooper is an academic researcher from University of Queensland. The author has contributed to research in topics: Diabetes mellitus & Diabetic nephropathy. The author has an hindex of 158, co-authored 1463 publications receiving 124887 citations. Previous affiliations of Mark E. Cooper include University of Cambridge & University of Adelaide.
Papers
More filters
Journal ArticleDOI
Peanut resistance to Sclerotinia minor and S. sclerotiorum
TL;DR: The comparative advantages of 3 strategies for Sclerotinia-resistant cultivar development are discussed: (1) introduction of germplasm; (2) recurrent backcrossing with screening and crossing in the BCnF1 generation; and (3) pedigree selection.
Journal ArticleDOI
Comparison of identity by descent and identity by state for detecting genetic regions under selection in a sorghum pedigree breeding program
David Jordan,David Jordan,Y. Z. Tao,Ian D. Godwin,R. G. Henzell,Mark E. Cooper,C. L. McIntyre +6 more
TL;DR: Allelic identities defined using IBD were much more sensitive for detecting non-Mendelian segregation in this pedigree and showed significant evidence of selection when IBS was used compared with ten regions with particular allelic identities when IBD was used.
Journal ArticleDOI
Synthesis of essramycin and comparison of its antibacterial activity.
TL;DR: The triazolopyrimidine natural product essramycin was synthesized without the use of protecting groups via a two-step reaction scheme involving a 3-amino-1,2,4-triazole intermediate, and its structure was unequivocally determined.
Journal ArticleDOI
Predicting grain yield in Australian environments using data from CIMMYT international wheat performance trials. 2. The application of classification to identify environmental relationships which exploit correlated response to selection
TL;DR: The theory for indirect selection is related to classification methodology for grouping of environments in plant breeding experiments and subsets of international environments which improved indirect response to selection in five of the six Australian environments are discussed.
Journal ArticleDOI
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)
Finnian R. Mc Causland,Brian Claggett,Emmanuel A. Burdmann,Glenn M. Chertow,Mark E. Cooper,Kai-Uwe Eckardt,Peter Ivanovich,Andrew S. Levey,Eldrin F. Lewis,Janet B. McGill,John J.V. McMurray,Patrick S. Parfrey,Hans-Henrik Parving,Giuseppe Remuzzi,Giuseppe Remuzzi,Ajay K. Singh,Scott D. Solomon,Robert D. Toto,Marc A. Pfeffer +18 more
TL;DR: Despite initiating dialysis therapy with a higher hemoglobin level, prior treatment with darbepoetin was not associated with a reduction in mortality, myocardial infarction, or heart failure in the first 180 days, but a higher frequency of stroke was observed.